Búsqueda Imágenes Maps Play YouTube Noticias Gmail Drive Más »
Búsqueda avanzada de patentes | Imágenes de página | Historial web | Iniciar sesión

Patentes

  
[merged small][graphic]

1 2 3 4 5 6 6 ? 8 9 10 11 12 13 14 15 16 B 17 18 19 B 20 21

[merged small][graphic]

1 2 3 4 5 B 6 7 8 9 10 11 12 13 14 6 15 16 17 18 19 20 21 22

[merged small][graphic][merged small][merged small][merged small][merged small][graphic]

1 2 3 4 5 6 7 8 9 10 tl 12 13 14 1516 17 18 19 20 21 22 23 24

[merged small][graphic]

1 2 3 4 5 6 7 8 9 10 1M2 131415 t61? 181320 21 2223 24 1 2

GENETIC MARKERS AND METHODS FOR Similarly. Tommassen et al. (WO 9011370) disclose poly

THE DETECTION OF ESCHERICHIA COLI nucleotide probes and methods for the identification and

SEROTYPE-0157:H7 detection of gram-positive bacteria. The method of Tommassen et al. relies on probes corresponding to relatively

FIELD OF INVENTION 5 short fragments of the outer membrane protein OmpA.

known to be highly conserved throughout gram-positive

The invention relates to the field of molecular biology and genera Aflas et al. (EP 517154) teach a nucleic acid hybrid

the use of randomly amplified nucleic acid fragments for the ization method for me detection of Giardia sp. based on

selection of genetic markers useful in the identification of designing probes with sequences complementary to regions

bacteria. More specifically, the invention relates to a specific of me gene encoding the giardin protein. Webster et al. (U.S.

DNA marker sequence useful for the detection of E. coli Pat No 4,7x7,653) has expanded upon the use of rRNA in

serotype 0157:H7 and use of that diagnostic marker to disclosing a method for the characterization of bacteria

determine if an unknown bacterium is a member of the based on ,he comparison 0f the chromatographic pattern of

0157:H7 serotype. restriction endonuclease-digested DNA from the unknown

BACKGROUND 15 or8anism witn equivalent chromatographic patterns of at

least 2 known different organism species. The digested DNA

Central to the field of microbiology is the ability to has been hybridized or reassociated with ribosomal RNA positively identify microorganisms at the level of genus, information-containing nucleic acid from, or derived from a species or serotype. Correct identification is not only an known probe organism. The method of Webster et al. essential tool in the laboratory, but it plays a significant role 2Q effectively establishes a unique bacterial nucleic acid "finin the control of microbial contamination in the processing gerprint" corresponding to a particular bacterial genus of food stuffs, the production of agricultural products, and against which unknown "fingerprints" are compared, the monitoring of environmental media such as ground Similar methods have been use for the detection of E. coli water. Increasing stringency in regulations which apply to 0157:H7. For example. Samadour (/. Clin. Microbiol. microbial contamination have resulted in a corresponding 2J (1995), 33(8). 2150-4) teaches the detection of E. coli increase in industry resources which must be dedicated to 0157:H7 by restriction fragment length polymorphism using contamination monitoring. Shiga-like toxin genes which are conserved between the

Of greatest concern is the detection and control of patho- 0157:H7 serotype and shigella. Similarly. Ramotar et al. (J.

genie microorganisms. Although a broad range of microor- Clin. Microbiol. (1995), 33(3). 519-24) and Fratamico et al.

ganisms have been classified as pathogenic, attention has 30 (J. Clin. Microbiol. (1995). 33(8), 2188-91) teach PGR

primarily focused on a few bacterial groupings such as basedmethods for the detection of conserved 0157 :H7 genes

Escherichia, Salmonella, Listeria and Clostridia. Typically. encoding either shiga-like toxins or verotoxins.

pathogen identification has relied on methods for distin- The methods described above are useful for the detection

guishing phenotypic aspects such as growth or motility 0f bacteria, but each relies upon knowledge of a gene,

characteristics, and for immunological and serological char- 35 protein, or other specific sequence known a priori to be

acteristics. Selective growth procedures and immunological highly conserved throughout a specific bacterial group. An

methods are the traditional methods of choice for bacterial alternative method would involve a nontargeted analysis of

identification and these can be effective for the presumptive bacterial genomic DNA for specific non-phenotypic genetic

detection of a large number of species within a particular markers common to all species of that bacteria. For example,

genus. However, these methods are time consuming and are 40 genetic markers based on single point mutations may be

subject to error. Selective growth methods require culturing detected by differentiating DNA banding patterns from

and subculturing in selective media, followed by subjective restriction enzyme analysis. As restriction enzymes cut DNA

analysis by an experienced investigator. Immunological at specific sequences, a point mutation within this site results

detection (e.g., ELISA) is more rapid and specific, however, in the loss or gain of a recognition site, giving rise in that

it still requires growth of a significant population of organ- 45 region to restriction fragments of different length. Mutations

isms and isolation of the relevant antigens. For these reasons caused by the insertion, deletion or inversion of DNA

interest has turned to detection of bacterial pathogens on the stretches will also lead to a length variation of DNA restric

basis of nucleic acid sequence. tion fragments. Genomic restriction fragments of different

It is well known, for example, that nucleic acid sequences lengths between genotypes can be detected on Southern

associated with the ribosomes of bacteria are often highly 50 blots (Southern. J. MoL Biol. 98, 503, (1975)). The genomic

conserved across genera and are therefore useful for iden- DNA is typically digested with any restriction enzyme of

tification (Webster, U.S. Pat. No. 4,717,653 and U.S. Pat choice, the fragments are electrophoretically separated, and

No. 5.087,558; Enns, Lab. Med., 19, 295, (1988); then hybridized against a suitably labelled probe for detec

Mordarski. Soc. Appl. Bacteriol. Tech. Ser., 20 (Chem. tion. The sequence variation detected by this method is

Methods Bad. Syst), 41. (1985)). Weisburg et al. (EP 55 known as restriction length polymorphism or RFLP

51736) disclose a method for the detection and identification (Botstein et al.. Am. J. Hum. Genet. 342,314, (1980)). RFLP

of pathogenic microorganisms involving the PCR amplifi- genetic markers are particularly useful in detecting genetic

cation and labeling of a target nucleotide for hybridization to variation in phenotypically silent mutations and serve as

16S rDNA of E. coli. Lane et al. (WO 9015157) teach highly accurate diagnostic tools.

universal nucleic acid probes that hybridize to conserved «) Another method of identifying genetic polymorphic

regions of 23S or 16S rRNA of eubacteria. markers employs DNA amplification using short primers of

Although bacterial ribosomal nucleic acids contain highly arbitrary sequence. These primers have been termed "ran

conserved sequences, they are not the only sources of base dom amplified polymorphic DNA" or "RAPD" primers (see

sequence conservation that is useful for microorganism Williams et al., Nucl. Acids. Res., 18,6531 (1990) and U.S.

identification. Wheatcroft et al. (CA 2055302) describe the 65 Pat. No. 5,126,239; also EP 0 543 484 A2, WO 92/07095,

selection of transposable elements, flanked by unique DNA WO 92/07948. WO 92/14844, and WO 92/03567). The

sequences, for the detection of various Rhizobium strains. RAPD method amplifies either double or single stranded

3

nontargeted, arbitrary DNA sequences using standard amplification buffers, DATP, dCTP. dGTP and TTP and a thermostable DNA polymerase such as Taq. The nucleotide sequence of the primers is typically about 9 to 13 bases in length, between 50 and 80% G+C in composition and 5 contains no palindromic sequences. RAPD detection of genetic polymorphisms represents an advance over RFLP in (hat it is less time consuming, more informative, and readily susceptible to automation. Because of its sensitivity for the detection of polymorphisms, RAPD analysis and variations 10 based on RAPD/PCR methods have become the methods of choice for analyzing genetic variation within species or closely related genera, both in the animal and plant kingdoms. For example. Landry et al. (Genome, 36.580. (1993)) discuss the use of RAPD analysis to distinguish various 15 species of minute parasitic wasps which are not morphologically distinct. Van Belkum et al. (Mol. Biochem Parasitol 61. 69. (1993)) teach the use of PCR-RAPD for the distinction of various species of Giardi.

In commonly assigned application U.S. Ser. No. 07/990, 20 297. U.S. Pat. No. 5.340.728, Applicants disclose a method of double-nested PCR which is used to detect the presence of a specific microbe. This disclosure first describes identifying a random, unique segment of DNA for each individual microorganism which will be diagnostic for that microor- 25 ganism. To identify and obtain this diagnostic nucleic acid segment a series of polymorphic markers is generated from each organism of interest using single primer RAPD analysis. The RAPD series from each organism is compared to similarly generated RAPD series for other organisms, and a 30 RAPD marker unique to all members of the group is then selected. The unique marker is then isolated, amplified and sequenced. Outer primers and inner primers suitable for double-nested PCR of each marker may then be developed. These primers comprise sequence segments within the 35 RAPD markers, wherein the inner set of primers will be complementary to the 3' ends of the target piece of nucleic acid. These nested primers may then be used for nested PCR amplification to definitely detect the presence of a specific microorganism. 40

In commonly owned PCT U.S. 95/06704, Applicants have more particularly adapted and described this RAPD methodology to identify a sequence, or marker. The presence of the marker is diagnostic for all individuals of the genus Salmonella. U.S. Ser. No. 08/254355 teaches a method 45 involving a RAPD amplification of genomic DNA of a representative number of Salmonella individuals to produce a RAPD amplification product, termed the diagnostic fragment. This diagnostic fragment must be present in the RAPD profiles in over 90% of the individuals tested. Sequence 50 information from the diagnostic fragment enables identification of the most suitable PCR primer binding sites within the diagnostic fragment to define a unique diagnostic marker. Primers flanking mis marker are useful for the generation of amplification products from Salmonella 55 genomic DNA. but will not produce any amplification products in non-Salmonella genera.

A detection methodology using PCR/RAPD specific to Escherichia coli 0157:H7 serotypes would be of high utility in the food industry. Detection methods not dependent on 60 sequences derived from a known gene or associated with a known phenotypic characteristic of E. coli 0157:H7 serotype have not previously been disclosed.

SUMMARY OF THE INVENTION 65 The present invention provides a method for the determination of diagnostic genetic markers for the specific

4

identification of E. coli 0157 :H7 serotype. The method comprises the following steps:

(i) performing a RAPD amplification on the genomic DNA of a representative number of individual E. coli 0157:H7 strains. These strains comprise the positive test panel. RAPD amplification performed on individuals of the positive test panel will generate a RAPD marker profile from each individual. The same RAPD amplification is performed on the genomic DNA of a significant number of individuals genetically unrelated to the positive test panel. In the present application non-0157 :H7 E. coli made up the negative test panel. RAPD amplifcation of the members of the negative test panel generated individual RAPD marker profiles as with the postive test panel;

(ii) comparing the RAPD marker profiles from individuals of the positive test panel with the RAPD marker profiles from individuals of the negative test panel and selecting a diagnostic nucleic acid fragment where the fragment is present in all of the RAPD marker profiles from the positive test panel and absent in the RAPD marker profiles from the negative test panel;

(iii) determining the nucleotide sequence of the diagnostic fragment to identify available primer binding sites;

(iv) preparing one or more pairs of primers corresponding to the available primer binding sites of step (iii);

(v) performing primer-directed amplification on the genomic DNA from members of the positive test panel using the primer pairs of step (iv). The amplification products of this step are compared against similar products generated by amplifications with the same primers against the negative test panel. Primers producing amplification products only in 0157:H7 serotypes and not in any other E. coli strains are then selected for their ability to amplify a specific 0157:H7 diagnostic marker.

(vi) Finally, the specificity of the primers selected in (v) are confirmed in a PCR assay against a large panel of 0157:H7 and non-0157:H7 strains.

In a preferred embodiment, the invention identifies the presence of 0157:H7 E. coli serotype by means of a PCR amplification assay using a first primer derived from a nucleic acid sequence (SEQ ID NO.: 1) and identified as SEQ ID NOS.: 3. 5, 7. and 9 and a second primer derived from a nucleic acid sequence (SEQ ID NO.: 2) and identified as SEQ ID NOS.: 4. 6, 8, and 10.

A further embodiment of the method uses a nucleic acid probe of a sequence complementary to that of a nucleic acid sequence (SEQ ID NOS.: 1 or 2 or a diagnostic marker fragment thereof). The nucleic acid probe hybridizes to the nucleic acid sequence acid and is detected. The presence of the hybridzed probe indicates the presence of the target nucleic acid sequence which in turn indicates the presence of a member of the E. coli 0157:H7 serotype.

This invention further provides isolated nucleic acid fragments having SEQ ID NOS.: 1-14.

BRIEF DESCRIPTION OF THE FIGURES

FIG. 1 is a gel showing RAPD patterns for E. coli strains comprising both the negative and positive test panels, amplified with the 12-mer primer 12CN07 (Table I).

FIG. 2 is the complete marker sequence illustrating the primer binding sites for the diagnostic primers 12CN07 (SEQ ID NO: 3and its reverse complement, SEQ ID NO: 4). 77-23-114, 77-26-111 (SEQ ID NO: 5 and its reverse complement, SEQ ID NO: 6), 77-26-538, 77-23-rc536, and 7111-26-rcI012.

« AnteriorContinuar »